Literature DB >> 15265035

Structural and functional analysis of ataxin-2 and ataxin-3.

Mario Albrecht1, Michael Golatta, Ullrich Wüllner, Thomas Lengauer.   

Abstract

Spinocerebellar ataxia types 2 (SCA2) and 3 (SCA3) are autosomal-dominantly inherited, neurodegenerative diseases caused by CAG repeat expansions in the coding regions of the genes encoding ataxin-2 and ataxin-3, respectively. To provide a rationale for further functional experiments, we explored the protein architectures of ataxin-2 and ataxin-3. Using structure-based multiple sequence alignments of homologous proteins, we investigated domains, sequence motifs, and interaction partners. Our analyses focused on presumably functional amino acids and the construction of tertiary structure models of the RNA-binding Lsm domain of ataxin-2 and the deubiquitinating Josephin domain of ataxin-3. We also speculate about distant evolutionary relationships of ubiquitin-binding UIM, GAT, UBA and CUE domains and helical ANTH and UBX domain extensions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15265035     DOI: 10.1111/j.1432-1033.2004.04245.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  53 in total

1.  Deubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain.

Authors:  Yuxin Mao; Francesca Senic-Matuglia; Pier Paolo Di Fiore; Simona Polo; Michael E Hodsdon; Pietro De Camilli
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-23       Impact factor: 11.205

Review 2.  Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes.

Authors:  Francisca E Reyes-Turcu; Karen H Ventii; Keith D Wilkinson
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

Review 3.  Evolutionary diversification of the Sm family of RNA-associated proteins.

Authors:  Douglas G Scofield; Michael Lynch
Journal:  Mol Biol Evol       Date:  2008-08-07       Impact factor: 16.240

4.  Ataxin-3 expression correlates with the clinicopathologic features of gastric cancer.

Authors:  Li-Xia Zeng; Yong Tang; Yun Ma
Journal:  Int J Clin Exp Med       Date:  2014-04-15

Review 5.  Machado-Joseph Disease: from first descriptions to new perspectives.

Authors:  Conceição Bettencourt; Manuela Lima
Journal:  Orphanet J Rare Dis       Date:  2011-06-02       Impact factor: 4.123

6.  Aggregation kinetics of interrupted polyglutamine peptides.

Authors:  Robert H Walters; Regina M Murphy
Journal:  J Mol Biol       Date:  2011-07-29       Impact factor: 5.469

7.  Therapeutic prospects for spinocerebellar ataxia type 2 and 3.

Authors:  Ilya Bezprozvanny; Thomas Klockgether
Journal:  Drugs Future       Date:  2009-12       Impact factor: 0.148

8.  Quercetin glycosides induced neuroprotection by changes in the gene expression in a cellular model of Parkinson's disease.

Authors:  Kasthuri Bai Magalingam; Ammu Radhakrishnan; Premdass Ramdas; Nagaraja Haleagrahara
Journal:  J Mol Neurosci       Date:  2014-08-17       Impact factor: 3.444

9.  Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2.

Authors:  Jing Liu; Tie-Shan Tang; Huiping Tu; Omar Nelson; Emily Herndon; Duong P Huynh; Stefan M Pulst; Ilya Bezprozvanny
Journal:  J Neurosci       Date:  2009-07-22       Impact factor: 6.167

10.  Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3.

Authors:  Fiona M Menzies; Jeannette Huebener; Maurizio Renna; Michael Bonin; Olaf Riess; David C Rubinsztein
Journal:  Brain       Date:  2009-12-09       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.